Munich - Delayed Quote EUR

Alnylam Pharmaceuticals Inc (DUL.MU)

136.40 -1.15 (-0.84%)
As of 8:00 AM GMT+2. Market Open.
Loading Chart for DUL.MU
DELL
  • Previous Close 137.55
  • Open 137.55
  • Bid 136.40 x --
  • Ask 137.75 x --
  • Day's Range 137.55 - 137.55
  • 52 Week Range 132.30 - 195.60
  • Volume 8
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 1, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: DUL.MU

Performance Overview: DUL.MU

Trailing total returns as of 6/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

DUL.MU
22.32%
S&P 500
10.64%

1-Year Return

DUL.MU
21.79%
S&P 500
23.24%

3-Year Return

DUL.MU
16.18%
S&P 500
25.41%

5-Year Return

DUL.MU
124.60%
S&P 500
91.77%

Compare To: DUL.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DUL.MU

Valuation Measures

Annual
As of 5/31/2024
  • Market Cap

    17.33B

  • Enterprise Value

    16.35B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    9.33

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    8.84

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: DUL.MU

Company Insights: DUL.MU

Research Reports: DUL.MU